Clinical Cancer Drugs
Title:Meet Our Editor-in-Chief
Volume: 4
Author(s): Giulio Francia*
Affiliation:
- The University of Texas El Paso, TX,United States
Export Options
About this article
Cite this article as:
Francia Giulio*, Meet Our Editor-in-Chief, Clinical Cancer Drugs 2017; 4 (1) . https://dx.doi.org/10.2174/2212697X0401170526184110
DOI https://dx.doi.org/10.2174/2212697X0401170526184110 |
Print ISSN 2212-697X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-6988 |
15
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Role of microRNA in Regulating Cell Signaling Pathways, Cell Cycle, and Apoptosis in Non-Small Cell Lung Cancer
Current Molecular Medicine Molecular Target-Guided Tumor Therapy with Natural Products Derived from Traditional Chinese Medicine
Current Medicinal Chemistry Innovative Anthocyanin/Anthocyanidin Formulation Protects SK-N-SH Cells Against the Amyloid-β Peptide-Induced Toxicity: Relevance to Alzheimer’s Disease
Central Nervous System Agents in Medicinal Chemistry Metabotropic Glutamate Receptor Dependent Cortical Plasticity in Chronic Pain
Current Neuropharmacology Crosstalk Between The Immune Receptors and Gut Microbiota
Current Protein & Peptide Science Antiestrogenically Active 2-benzyl-1,1-diarylbut-2-enes: Synthesis, Structure- Activity Relationships and Molecular Modeling Study for Flexible Estrogen Receptor Antagonists
Medicinal Chemistry Biomarkers of Angiogenesis and their Role in Patient Selection for Antiangiogenic Therapy
Current Angiogenesis (Discontinued) Ribosomal Proteins and Colorectal Cancer
Current Genomics Metal Containing Chloroquinolines: Beyond Hit and Miss Antimalarial Efficacy to Solid Science
Mini-Reviews in Medicinal Chemistry Cyclin-Dependent Kinase-2 as a Target for Cancer Therapy: Progress in the Development of CDK2 Inhibitors as Anti-Cancer Agents
Current Medicinal Chemistry Determinants of Treatment Outcomes for Hepatitis C Infection and the Path to Personalized Medicine
Current Pharmacogenomics and Personalized Medicine Preface [Hot Topic: Multifunctional Drug Targets (Executive Editors: H.E. Tibbles and A.O. Vassilev)]
Current Pharmaceutical Design Novel Aminopeptidase N Inhibitors with Improved Antitumor Activities
Letters in Drug Design & Discovery Humoral and Mechanical Cross-Talk in the Vasculature: Perspectives in Vascular Disease
Vascular Disease Prevention (Discontinued) Block Copolymers for Drug Delivery Nano Systems (DDnSs)
Current Medicinal Chemistry Editorial [Hot Topic: Angiogenesis in Tumor Growth and Metastasis (Executive Editor: Riichiro Abe)]
Current Pharmaceutical Design Progress in Imaging Agents of Cell Apoptosis
Anti-Cancer Agents in Medicinal Chemistry Graphical Abstracts:
Current Radiopharmaceuticals Innate Immune System Modulation During Aging: Contributions of Macrophages and Dendritic Cells
Current Immunology Reviews (Discontinued) Radioprotective Gene Therapy
Current Gene Therapy